View in EDS

ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/ESE3 signalling axis.

Saved in:
Bibliographic Details
Title: ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/ESE3 signalling axis.
Authors: Zhao, Tiansuo1 (AUTHOR), Xiao, Di1 (AUTHOR), Jin, Fanjie1 (AUTHOR), Sun, Xugang1 (AUTHOR), Yu, Jie2 (AUTHOR), Wang, Hongwei1 (AUTHOR), Liu, Jing1 (AUTHOR), Cai, Wenrun1 (AUTHOR), Huang, Chongbiao1 (AUTHOR), Wang, Xiuchao1 (AUTHOR), Gao, Song1 (AUTHOR), Liu, Zhe3 (AUTHOR), Yang, Shengyu4 (AUTHOR), Gao, Chuntao1 (AUTHOR) gaochuntao@tjmuch.com, Hao, Jihui1 (AUTHOR) haojihui@tjmuch.com
Source: British Journal of Cancer. Nov2022, Vol. 127 Issue 8, p1461-1472. 12p.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/s41416-022-01927-y